New research from ACG 2024 reveals that primary sclerosing cholangitis raises colorectal cancer risk even in patients without ...

Primary sclerosing cholangitis (PSC) is a liver disease that leads to progressive destruction and stricturing of the biliary tree. Unfortunately, apart from orthotopic liver transplantation (OLT), ...

Rectify Pharmaceuticals Inc. has nominated the positive functional modulator (PFM) RTY-694 as a development candidate for primary sclerosing cholangitis (PSC). As the lead PFM in Rectify’s ...

Sclerotherapy is a widely-used, minimally invasive procedure for treating varicose veins and spider veins. The process ...

I DON’T care what the medics say, it's not my time,” said a brave mother who is determined to beat her terminal cancer ...

SOUTH SAN FRANCISCO, Nov. 06, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: PLRX), today announced that Keith Cummings, M.D., Chief ...

The Hall of Fame tailback and undersized fullback lived out a "new version of 'Brian's Song'" in the last months of Payton's ...

AX-0810 targeting NTCP for cholestatic diseases to be first ProQR Axiomer™ RNA editing program to enter the clinic Company to host virtual ...

Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (“Chemomab” or the “Company”), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, ...